According to a press release, the CBD isolate will be available from retailers nationwide. Ontario’s MediPharm Labs Corp. has launched a new line of THC-free, 99 per cent pure CBD crystalline isolate to be sold under the LABS Cannabis banner. Ottawa to form advisory committee after Canadians voice interest in ‘cannabis health products’ Long-term cannabis use for chronic pain in seniors found not to be associated with cognitive performance Can medical cannabis help treat clinical burnout? A Health Canada report released earlier this year found that nearly 70 per cent of respondents (about 1,100 people) were interested in “cannabis health products,” particularly to treat pain and inflammation. They also “expressed a strong interest in CBD.” Seniors, veterans, athletes and women experiencing menopause were all groups of interest.
Ontario’s MediPharm Labs Corp. has launched a new line of THC-free, 99 per cent pure CBD crystalline isolate to be sold under the LABS Cannabis banner.
According to a press release, it’s the first product of its kind in Canada.
“Produced at commercial scale, LABS Cannabis CBD Isolate has only trace amounts of THC — less than 0.2 per cent — which makes it an excellent choice for a broad range of wellness consumers and patients seeking the potential benefits...
Read the full article @ The Growth Op